NCT03940066Completed
Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile
Source: ClinicalTrials.gov · Last updated 6 Apr 2025
Brief summary (registry, in English)
The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 169 (actual)
- First submitted
- 5 May 2019
- Start date
- 12 Nov 2019
- Primary completion date
- 8 Apr 2024
- Lead sponsor
- Fundación EPIC
- NCT number
- NCT03940066
What you commit to
- Study type: Interventional
- Participants enrolled: 169
- From 12 Nov 2019 to the primary completion date, 8 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient with pacemaker or ICD (implantable cardioverter-defibrillator) previously.
Other illness
- Patient with history of AF.
Other
- Patient with episodes of AF during admission at the current episode.
- Patient with indication of pacemaker or ICD in current or short-term phase.
- Patient is participating in another interventional clinical investigation.
- Patient is pregnant or breast feeding.
- Patient´s life-expectancy is less than 24 months.
Who the study is looking for
- Patient is able to understand the nature of study and has provided written informed consent.
- Patient with Acute Coronary Syndrome, with or without elevation of the ST segment at the EKG (the last with elevation of troponins).
- Patient with coronariography at the episode of ACS showing severe lesions treated with stent.
- Patient with risk index for 6-month mortality (GRACE score) of more than 118.
- Patient with risk index for stroke (CHA2DS2-VACS score) of more than 2.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Marqués de Valdecilla Coordinator of this site? Confirm its status | Santander | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.